Xiao E, Hu G, Liu P, Hu D, Liu S, Hao C
Department of Radiology, Tongji Hospital, Tongji Medical University, Wuhan 430030.
J Tongji Med Univ. 2000;20(3):231-4. doi: 10.1007/BF02887000.
To study the effect of the different interventional treatment on P-Glycoprotein (Pgp) in different histopathological types of primary hepatocellular carcinoma (PHC), 98 surgically and histologically verified PHC specimens were obtained. The patients included 57 patients treated by surgical resection alone and 41 patients receiving second-stage surgical resection after four kinds of interventional treatment. SABC immunohistochemical staining with a monoclonal antibody against human Pgp was used to observe the Pgp in all specimens. The positive rate of Pgp was 100% in group of chemotherapy alone (P < 0.05), 62.5% in group of chemotherapy combined with iodized oil (P > 0.05), 46.6% in group of chemotherapy combined with iodized oil and spongia gelatini absorbens (Sga) (P > 0.05), 18.18% in group of chemotherapy combined with Ethanol-iodized-oil and Sga (P < 0.05) and 52.63% in group of surgical resection alone. The positive rate of Pgp varied with different histopathological types, with rate of clear cell PHC being the lowest, and that of poorly differentiated or undifferentiated PHC the highest. The positive rate of Pgp was increased as pathological grades increased. Overexpression of Pgp may be responsible for the intrinsic and acquired drug resistance of PHC. Multidrug resistance (MDR) varied with different histological types. Therapy of PHC should be tailored according to individual. Local chemotherapy combined with ethanol-iodized-oil and Sga embolization may become a new way to overcome MDR of PHC.
为研究不同介入治疗对不同组织病理学类型原发性肝癌(PHC)中P-糖蛋白(Pgp)的影响,获取了98例经手术及组织学证实的PHC标本。患者包括57例单纯接受手术切除的患者以及41例在接受四种介入治疗后接受二期手术切除的患者。采用抗人Pgp单克隆抗体的SABC免疫组化染色法观察所有标本中的Pgp。单纯化疗组Pgp阳性率为100%(P<0.05),化疗联合碘化油组为62.5%(P>0.05),化疗联合碘化油及吸收性明胶海绵(Sga)组为46.6%(P>0.05),化疗联合乙醇碘化油及Sga组为18.18%(P<0.05),单纯手术切除组为52.63%。Pgp阳性率随不同组织病理学类型而变化,透明细胞型PHC的阳性率最低,低分化或未分化型PHC的阳性率最高。Pgp阳性率随病理分级增加而升高。Pgp的过表达可能是PHC固有和获得性耐药的原因。多药耐药(MDR)随不同组织学类型而变化。PHC的治疗应个体化。局部化疗联合乙醇碘化油及Sga栓塞可能成为克服PHC多药耐药的新途径。